AgingNCT06921057
Effects of Exergames on Muscle and Lung Function in Elderly
A study testing exergame in people with Aging, run by Chang Gung University at 1 site in Taiwan.
Trial summary
The goal of this study is to examine the effects of 8-weeks exergames program on pulmonary function, muscle strength and cognitive function in elderly. Participants will: Play exergame 30min/session, 2 sessions/week or remained regular daily activities for 8 weeks. Read more about this study
- Who is it for?
- Ages 60 years and olderHealthy volunteers can take part
- Conditions the study is for
- Aging
- What is being tested?
- exergame
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 34 participants
- Where
- 1 siteTaiwan
- Study dates
- 4 Sep 2023to 29 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- age > 60 years,
- sufficient cognitive capacity to provide informed consent,
- ability to understand and speak Chinese or Taiwanese.
Who cannot join
- medical conditions prohibiting physical exercise
- physical or cognitive disabilities preventing participation in or comprehension of the exergame.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Exergames on Muscle Strength and Lung Function in Elderly
The goal of this study is to examine the effects of 8-weeks exergames program on pulmonary function, muscle strength and cognitive function in elderly.
Participants will:
Play exergame 30min/session, 2 sessions/week or remained regular daily activities for 8 weeks.
Read the detailed description
Subjects who are older than 60 years will be assigned to exergame group or control group randomly.
Exergame group: Subjects will receive exergame program 30min/session, 2 sessions/week for 8 weeks.
Control group: Subjects remain regular daily activities for 8 weeks. Both groups receive pre- and post- measurements. The measurements included assessment of muscle strength and lung function.
- Conditions
- Aging
- Being tested
- exergame
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
exergameOther
playing exergames
| Study group | Role | What they receive |
|---|---|---|
| exergame | Experimental | playing exergame 30 min/session, 2 sessions/ week, for 8 weeks. Receives: Other: exergame |
| Control | No intervention | remain regular activities for 8 weeks. |
What is being measured
The primary outcome is the main question the study is designed to answer.
forced expiratory volume at 1 sec (L)
forced expiratory volume at 1sec
Measured: week 0 and week 8
forced expiratory volume at 1 sec (%)
percentage of forced expiratory volume at 1sec predicted value
Measured: week 0 and week 8
forced vital capacity(L)
forced vital capacity
Measured: week 0 and week 8
forced vital capacity(%)
percentage of forced vital capacity predicted value
Measured: week 0 and week 8
arm curl test
measurement upper arm muscle strength
Measured: week 0 and week 8
hand grip strength
measurement upper arm muscle strength
Measured: week 0 and week 8
Mini-Mental State Examination
assessment of cognitive function
Measured: week 0 and week 8
Montreal Cognitive Assessment
assessment of cognitive function
Measured: week 0 and week 8
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Apr 2025
- Study start4 Sep 2023
- Primary completion29 Dec 2023
- Study completion29 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AgingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 34 participants (actual)
Sponsor and investigators
- Lead sponsor
- Chang Gung University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Chen Yen-Huey, Chang Gung University
- Investigators
- Yen-Huey Chen, PhD, Principal investigator, Chang Gung University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06921057
- Sponsor's protocol ID
- 202301151B0
- Status last verified
- Apr 2025
- First submitted
- 31 Mar 2025
- Last updated
- 10 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: all collected IPD, that underlie results in a publication
Study at a glance
From the registry record, last updated by the sponsor on 10 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Exergames on Muscle Strength and Lung Function in Elderly
- ClinicalTrials.gov ID
- NCT06921057
- Acronym / sponsor ID
- 202301151B0
- Conditions
- Aging
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 34 participants (actual)
- Lead sponsor
- Chang Gung UniversityUniversity, hospital or other
- Study start
- 4 Sep 2023 (actual)
- Primary completion
- 29 Dec 2023 (actual)
- Study completion
- 29 Dec 2023 (actual)
- First posted
- 10 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to examine the effects of 8-weeks exergames program on pulmonary function, muscle strength and cognitive function in elderly.
Participants will:
Play exergame 30min/session, 2 sessions/week or remained regular daily activities for 8 weeks.
Detailed description
Subjects who are older than 60 years will be assigned to exergame group or control group randomly.
Exergame group: Subjects will receive exergame program 30min/session, 2 sessions/week for 8 weeks.
Control group: Subjects remain regular daily activities for 8 weeks. Both groups receive pre- and post- measurements. The measurements included assessment of muscle strength and lung function.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| exergame | Experimental | Other: exergameplaying exergame 30 min/session, 2 sessions/ week, for 8 weeks. |
| Control | No intervention | –remain regular activities for 8 weeks. |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- age > 60 years,
- sufficient cognitive capacity to provide informed consent,
- ability to understand and speak Chinese or Taiwanese.
Key exclusion criteria (2 listed)
- medical conditions prohibiting physical exercise
- physical or cognitive disabilities preventing participation in or comprehension of the exergame.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| exergameplaying exergames | Other | exergame |
Primary outcome
forced expiratory volume at 1 sec (L)
Time frame: week 0 and week 8
forced expiratory volume at 1sec
forced expiratory volume at 1 sec (%)
Time frame: week 0 and week 8
percentage of forced expiratory volume at 1sec predicted value
forced vital capacity(L)
Time frame: week 0 and week 8
forced vital capacity
forced vital capacity(%)
Time frame: week 0 and week 8
percentage of forced vital capacity predicted value
arm curl test
Time frame: week 0 and week 8
measurement upper arm muscle strength
hand grip strength
Time frame: week 0 and week 8
measurement upper arm muscle strength
Mini-Mental State Examination
Time frame: week 0 and week 8
assessment of cognitive function
Montreal Cognitive Assessment
Time frame: week 0 and week 8
assessment of cognitive function
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Apr 2025.
- Individual participant dataSharing planned: Yes. all collected IPD, that underlie results in a publication
Related trials for Aging
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
RecruitingPhase 2
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
Multiple Sclerosis
Not yet recruitingPhase 2
Validation & Intervention Testing for Aging, Longevity and Healthspan
Aging, Functional Decline
RecruitingObservational study
Effects of Obesity on Physical Abilities and Daily Living Activities in Elderly Adults
Obesity, Sarcopenic Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yen-Huey Chen, PhD principal investigator
Chang Gung University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing exergame in people with Aging, run by Chang Gung University at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
forced expiratory volume at 1 sec (L) (time frame: week 0 and week 8). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2025.